CAI:NIPH (Egypt)
Â
E£
184.9
+8.69 (+4.93%)
Jul 14
Business Description
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile
ISIN : EGS38331C012
Compare
Compare
Traded in other countries / regions
NIPH.Egypt IPO Date
1995-02-27Description
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile manufactures and markets pharmaceuticals, medicinal materials, chemical products and surgical threads and medical solutions.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.19 | |||||
Debt-to-EBITDA | 2.48 | |||||
Interest Coverage | 1.57 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 4.27 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 79.73 | |||||
9-Day RSI | 72.13 | |||||
14-Day RSI | 68.13 | |||||
3-1 Month Momentum % | 61.09 | |||||
6-1 Month Momentum % | 74.02 | |||||
12-1 Month Momentum % | 335.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 120.71 | |||||
Days Sales Outstanding | 106.47 | |||||
Days Payable | 39.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.08 | |||||
Dividend Payout Ratio | 0.39 | |||||
Forward Dividend Yield % | 1.08 | |||||
5-Year Yield-on-Cost % | 1.14 | |||||
Shareholder Yield % | 1.13 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.4 | |||||
Operating Margin % | 15.17 | |||||
Net Margin % | 10.72 | |||||
EBITDA Margin % | 23.53 | |||||
FCF Margin % | -12.04 | |||||
OCF Margin % | 16.53 | |||||
ROE % | 24.41 | |||||
ROA % | 8.09 | |||||
ROIC % | 12.01 | |||||
ROC (Joel Greenblatt) % | 34.37 | |||||
ROCE % | 36.84 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 36.69 | |||||
PE Ratio without NRI | 35.74 | |||||
PS Ratio | 3.93 | |||||
PB Ratio | 8.37 | |||||
Price-to-Tangible-Book | 8.38 | |||||
Price-to-Operating-Cash-Flow | 22.85 | |||||
EV-to-EBIT | 19.99 | |||||
EV-to-EBITDA | 19.99 | |||||
EV-to-Revenue | 4.7 | |||||
EV-to-FCF | -37.7 | |||||
Price-to-Graham-Number | 3.65 | |||||
Earnings Yield (Greenblatt) % | 5 | |||||
FCF Yield % | -2.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil E£) | 2,239.153 | ||
| EPS (TTM) (E£) | 5.039 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 1.34 | ||
| 3-Year Sortino Ratio | 5.79 | ||
| Volatility % | 84.94 | ||
| 14-Day RSI | 68.13 | ||
| 14-Day ATR (E£) | 6.520111 | ||
| 20-Day SMA (E£) | 169.237 | ||
| 12-1 Month Momentum % | 335.63 | ||
| 52-Week Range (E£) | 37.748266 - 186.89 | ||
| Shares Outstanding (Mil) | 50 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Stock Events
| Event | Date | Price (E£) | ||
|---|---|---|---|---|
| EGP 2.000000 Cash Dividend | 2025-10-29 | 131.74 (-8.52%) | ||
| EGP 2.469513 Cash Dividend | 2024-11-19 | 37.89 (+6.23%) | ||
| 1.5:1 Stock Split | 2011-01-20 | 10.96 (+0.96%) | ||
| 1.5:1 Stock Split | 2009-05-28 | 7.44 (-6.49%) | ||
| 1.5:1 Stock Split | 2007-03-08 | 8.24 (+0.00%) |
Show
Entries
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Frequently Asked Questions
What is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile(CAI:NIPH)'s stock price today?
The current price of CAI:NIPH is E£184.90. The 52 week high of CAI:NIPH is E£186.89 and 52 week low is E£37.75.
When is next earnings date of El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile(CAI:NIPH)?
The next earnings date of El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile(CAI:NIPH) is .
Does El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile(CAI:NIPH) pay dividends? If so, how much?
The Dividend Yield %  of El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile(CAI:NIPH) is 1.08% (As of Today), Highest Dividend Payout Ratio of El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile(CAI:NIPH) was 0.89. The lowest was 0.39. And the median was 0.72. The  Forward Dividend Yield % of El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile(CAI:NIPH) is 1.08%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers